Upcoming Webinars

An Investigation into Integration of Disposable Components into Traditional Stainless-steel Facilities

Presented by Ron Bates, Bristol-Myers Squibb and Miriam Monge, Sartorius Stedim biotech Integrated Solutions
22nd May 2018

Environmental Monitoring Trend Analysis Tools

Presented by Steve Walton, Technical Manager in Sterility Assurance with Sanofi Pasteur, Toronto
23rd May 2018

Current USP Perspectives on a Rapid Sterility Test

Presented by Presented by Dr David Roesti, Novartis/USP
30th May 2018

Extractable Study Design and Data Evaluation of Polymeric Product Contact Materials

Presented by Dr. Ping Wang, Principal Scientist, Janssen R&D and Dr Nixdorf, SGS Group
05th June 2018

Finding the Common Road to Quality for Single Use Materials

Presented by Dr Trishna Ray-Chaudhuri, Genentech and Dr Hélène Pora & Dr James Hathcock of Pall Biotech
06th June 2018

Preview of USP’s Informational Chapter <1085>, “Guidelines on the Endotoxins Test”

Presented by Karen Zink McCullough & Kevin L. Williams
11th June 2018

Fully continuous biosimilar manufacturing framework: A case study

Presented by Samir Varma, Head of Manufacturing, Enzene Biosciences
14th June 2018

Manufacturing strategies for Biosimilar: A case of continuous capture

Presented by Solomon Alva, Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited
15th June 2018

mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO, Genor Biopharma, Walvax Bio Group and Floris De Smet, Sartorius Stedim Biotech
18th June 2018

Platform technology development for biosimilar upscaling

Presented by Dr H. Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech
21st June 2018

Challenges in the Development of Continuous Processes for Vaccines

Presented by Danny Vellom of Sanofi Pasteur Biologics, Inc.
27th June 2018

Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay

Presented by Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX
28th June 2018

Raman spectroscopy measurements during Bioprocessing

Presented by Nobel Vale, Research Scientist II, Bristol-Myers Squibb
11th July 2018

Development and Manufacturing of Recombinant Nanoparticle Vaccines

Presented by Atin Tomar, President & CEO, CPL Biologicals Pvt. Ltd and Stefan Schlack, Senior Vice President of Marketing & Product Management, Sartorius Stedim Biotech
12th July 2018

Key components of a comprehensive program for the management of single use technologies in biologics manufacturing

Presented by John Maguire, Shire and Donald Young, ThermoFisher Scientific
18th July 2018

Quality-By-Design in Spray Drying Processes – Transfer Lab to Production

Presented by Sune Klint Andersen and Filipe Gaspar, Hovione FarmaCiência
25th July 2018

Lifecycle management of single use technologies

Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
25th July 2018

Subvisible Particles Matter, Developments in Regulations and Low Volume Methods

Presented by Dr Satish K Singh, Lonza
26th July 2018

Next generation processes: What model works the best in Asia?

Presented by Ravishankar Kasturi, Vice President, Head of Manufacturing & Process Development, Reliance Life Sciences
09th August 2018

Mixed mode Chromatography in Purifying biologics – Overview

Presented by Vivek Halan, Senior Scientific manager, Zumutor Biologics Pvt Ltd
13th August 2018

Is India Anywhere Closer to Implementing Continuous Bioprocessing

Presented by Narasimha Rao Nedunuri, Managing Director of CLONZ
16th August 2018

Implementing CMC Strategies for scale-up operations in biologics manufacturing

Presented by Dr Anita Krishnan, Principal Scientist Lupin Ltd
20th August 2018

Material Understanding for Continuous Manufacturing of Solid Dosage Forms

Presented by Dr Yifan Wang, Regulatory Research Scientist, FDA CDER
23rd August 2018

Project and Portfolio Management as a key tool to manage continuous improvement in bio-pharma manufacturing

Presented by Gloria Gadea-Lopez, Ph.D.and Melvin Santos, Shire
06th September 2018

Efficiency by Design – Case Study for a Hybrid Clinical Manufacturing Facility

Presented by Dr Sourav Kundu, Senior Director, Process Development and Clinical manufacturing, Teva Pharmaceuticals
12th September 2018

Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up

Presented by Dr. Jincai Li, Vice President of WuXi Biologics
14th September 2018

DSF and FTIR as complementary methods for the identification and characterization of vaccine products

Presented by Marina Kirkitadze, Deputy Director, Head of Biophysics & Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur and Rina Dukor, President, BioTools
18th September 2018

Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis
27th September 2018

Impact of Depth Filtration on Disulfide Bond Reduction during Downstream Processing of Monoclonal Antibodies from CHO Cell Cultures

Presented by Brian O'mara, Senior Research Scientist I, Bristol-Myers Squibb
08th October 2018

Extractables and leachables testing using a Quality Risk Management approach

Presented by Dhaval Tapiawala, Principal Scientist, Pfizer
17th October 2018

Application of Multivariate Data Analysis for Process Diagnostic and Root Cause Analysis

Presented by Ramila Peiris, Ph.D., Manager, Process Modelling and Process Analytical Technology, Sanofi Pasteur
23rd October 2018

Advances and Challenges in Vaccine Development and Manufacture

Presented by Tony D'Amore, Vice Preseident, Product Research & Development, Sanofi Pasteur
02nd November 2018

Regulatory Approval of Three Rapid Microbiological Methods for MACI Product Release

Presented by John Duguid
08th November 2018

Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented by Yuyi Shen, Principal Scientist, Grifols
19th November 2018

Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry

Presented by Don Singer
09th January 2019